Your browser doesn't support javascript.
loading
A clinically relevant selective ERK-pathway inhibitor reverses core deficits in a mouse model of autism.
Murari, Kartikeya; Abushaibah, Abdulrahman; Rho, Jong M; Turner, Ray W; Cheng, Ning.
Affiliation
  • Murari K; Hotchkiss Brain Institute, Cumming School of Medicine, University of Calgary, Canada; Department of Biomedical Engineering, Schulich School of Engineering, University of Calgary, Canada; Department of Electrical and Software Engineering, Schulich School of Engineering, University of Calgary, Canada.
  • Abushaibah A; Alberta Children's Hospital Research Institute, Cumming School of Medicine, University of Calgary, Canada; Bachelor of Health Sciences, Cumming School of Medicine, University of Calgary, Canada.
  • Rho JM; Hotchkiss Brain Institute, Cumming School of Medicine, University of Calgary, Canada; Alberta Children's Hospital Research Institute, Cumming School of Medicine, University of Calgary, Canada.
  • Turner RW; Hotchkiss Brain Institute, Cumming School of Medicine, University of Calgary, Canada; Alberta Children's Hospital Research Institute, Cumming School of Medicine, University of Calgary, Canada; Department of Cell Biology & Anatomy, Cumming School of Medicine, University of Calgary, Canada.
  • Cheng N; Hotchkiss Brain Institute, Cumming School of Medicine, University of Calgary, Canada; Alberta Children's Hospital Research Institute, Cumming School of Medicine, University of Calgary, Canada; Department of Comparative Biology and Experimental Medicine, Faculty of Veterinary Medicine, University of
EBioMedicine ; 91: 104565, 2023 May.
Article in En | MEDLINE | ID: mdl-37088035

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Autistic Disorder / Autism Spectrum Disorder Type of study: Prognostic_studies Limits: Animals Language: En Journal: EBioMedicine Year: 2023 Document type: Article Affiliation country: Canada

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Autistic Disorder / Autism Spectrum Disorder Type of study: Prognostic_studies Limits: Animals Language: En Journal: EBioMedicine Year: 2023 Document type: Article Affiliation country: Canada